Dueñas-García OF, Ramírez-Torres A, Diaz-Sotomayor M, Rico-Olvera H

Language: Spanish
References: 11
Page: 411-418
PDF size: 324.35 Kb.

ABSTRACT

Background: Gestational diabetes is one of the most common diseases during pregnancy. Despite this situation, there is still no consensus on methods for screening and diagnosis of this disease.
Objective: To assess perinatal outcomes of patients with gestational diabetes diagnosed using three different methods.
Patients and methods: Clinical observational, longitudinal, randomized trial at the National Institute of Perinatology Isidro Espinosa de los Reyes. We included all patients admitted to the Institute for a period of three months without pregestational diabetes. Patients were screened for gestational diabetes with an oral load of 50 g of glucose. Patients with a positive screen were randomized by a computer program that randomly chose patients and made a curve according to the criteria of the American Diabetes Association 75 g or 100 g and another group with 75 g according to the criteria of the World Health Organization. Patients with gestational diabetes were followed throughout pregnancy until its reclassification in the puerperium.
Results: Screening was performed in 863 patients and 87 were diagnosed with gestational diabetes. Perinatal outcomes were similar in patients with gestational diabetes diagnosed using different methods, but there was a higher frequency of pregnancy-induced hypertension in patients diagnosed with the curves of the American Diabetes Association 75 and 100 g compared with the curve of the World Health Organization.
Conclusions: The American Diabetes Association diagnostic method as the World Health Organization are acceptable forms to diagnose gestational diabetes.

REFERENCES

1. Vidaeff A, Yeomans E, Ramin S. Gestational Diabetes: A field of Controversy. Obstet Gynecol Survey 2003;58:759-769.

2. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010;33:S62.

3. Tamez H, Rodríguez M, Treviño M, Espinosa J, et al. Experiencia con un programa de escrutinio de diabetes gestacional. Rev Invest Clin 1993;45:453-456.

4. Gutiérrez HI, Carrillo M, Pestaña S, Santamaría M. Pacientes diabéticas embrazadas: experiencia institucional. Ginecol Obstet Mex 2006;74:187-192.

5. Rodríguez M, Mejia E, Hernandez P, Vargas R, Novoa A, Velparde E. Modificación del punto de corte en la prueba de cribado para el diagnóstico de diabetes gestacional. Ginecol Obstet Mex 2006;74:247-251.

6. O’Sullivan JB, Mahan CM, Charles D, Dandrow RV. Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 1973;116: 895-900.

7. Crowther, CA, Hiller, JE, Moss, JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-2486.

8. Tieu J, Middleton P, McPhee AJ, Crowther CA. Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007222.

9. Norma Oficial Mexicana NOM-007-SSA2-1993. Atención de la mujer durante el embarazo, parto y puerperio y del recién nacido. Criterios y procedimientos para la prestación del servicio.

10. Brody SC. Screening for Gestational Diabetes: A summary of the evidence for the US Preventive Services Task Force. Obstet Gynecol 2003;101:380-392.

11. Nolan CJ. Controversies in gestational diabetes. Obstet Gynaecol 2011;25(1):37-49.